These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29762171)

  • 21. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence network effectiveness in promoting couples' HIV voluntary counseling and testing in Kigali, Rwanda.
    Wall K; Karita E; Nizam A; Bekan B; Sardar G; Casanova D; Joseph Davey D; De Clercq F; Kestelyn E; Bayingana R; Tichacek A; Allen S
    AIDS; 2012 Jan; 26(2):217-27. PubMed ID: 22008653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up.
    Apondi R; Bunnell R; Ekwaru JP; Moore D; Bechange S; Khana K; King R; Campbell J; Tappero J; Mermin J
    AIDS; 2011 Jun; 25(10):1317-27. PubMed ID: 21522005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; March L; Kouanfack C; Bonono RC; Boyer S; Laborde-Balen G; Aghokeng A; Suzan-Monti M; Delaporte E; Spire B; Carrieri MP; Laurent C;
    HIV Med; 2014 Sep; 15(8):478-87. PubMed ID: 24589279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    Steegen K; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; Variava E; MacLeod W; Sanne I; Stevens WS; Carmona S
    J Antimicrob Chemother; 2017 Jan; 72(1):210-219. PubMed ID: 27659733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.
    Ndahimana Jd; Riedel DJ; Muhayimpundu R; Nsanzimana S; Niyibizi G; Mutaganzwa E; Mulindabigwi A; Baribwira C; Kiromera A; Jagodzinski LL; Peel SA; Redfield RR
    Antivir Ther; 2016; 21(3):253-9. PubMed ID: 26562173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.
    Bunnell R; Ekwaru JP; Solberg P; Wamai N; Bikaako-Kajura W; Were W; Coutinho A; Liechty C; Madraa E; Rutherford G; Mermin J
    AIDS; 2006 Jan; 20(1):85-92. PubMed ID: 16327323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge, use, and concerns about contraceptive methods among sero-discordant couples in Rwanda and Zambia.
    Grabbe K; Stephenson R; Vwalika B; Ahmed Y; Vwalika C; Chomba E; Karita E; Kayitenkore K; Tichacek A; Allen S
    J Womens Health (Larchmt); 2009 Sep; 18(9):1449-56. PubMed ID: 19708802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and perceptions of couples' voluntary counseling and testing in urban Rwanda and Zambia: a cross-sectional household survey.
    Kelley AL; Karita E; Sullivan PS; Katangulia F; Chomba E; Carael M; Telfair J; Dunham SM; Vwalika CM; Kautzman MG; Wall KM; Allen SA
    PLoS One; 2011 May; 6(5):e19573. PubMed ID: 21573068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia.
    Khu NH; Vwalika B; Karita E; Kilembe W; Bayingana RA; Sitrin D; Roeber-Rice H; Learner E; Tichacek AC; Haddad LB; Wall KM; Chomba EN; Allen SA
    Contraception; 2013 Jul; 88(1):74-82. PubMed ID: 23153896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
    Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of couples' voluntary HIV counselling and testing in six African countries: a modelling study guided by an HIV prevention cascade framework.
    Wall KM; Inambao M; Kilembe W; Karita E; Chomba E; Vwalika B; Mulenga J; Parker R; Sharkey T; Tichacek A; Hunter E; Yohnka R; Streeb G; Corso PS; Allen S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25522. PubMed ID: 32602618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.